Older people tend to get more Botox injections than younger people when treating frown lines.
Scientific Claim
Age is positively associated with the total number of botulinum toxin type A (BoNT-A) units administered in glabellar treatment, based on observations in a sample of 58 adults.
Original Statement
“Regarding muscle strength pattern, more units were used in the corrugator muscle with a strong pattern and facial wrinkle classification of 3-4 and moderate with the same wrinkle classification (8U and 8.5U, respectively). In the procerus muscle, more units were used in the strong force pattern with wrinkles classified as 3-4 (5U). Wrinkles classified as 3-5 required the highest number of BoNT-A units. A positive correlation between the number of units used and the age of the 58 participants.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract uses 'positive correlation,' which is acceptable, but the claim must avoid implying causation (e.g., aging causes higher doses). The association may reflect confounding by wrinkle severity or muscle strength.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Prospective Cohort StudyLevel 2bWhether increasing age independently predicts higher BoNT-A dose requirements after adjusting for wrinkle severity and muscle strength.
Whether increasing age independently predicts higher BoNT-A dose requirements after adjusting for wrinkle severity and muscle strength.
What This Would Prove
Whether increasing age independently predicts higher BoNT-A dose requirements after adjusting for wrinkle severity and muscle strength.
Ideal Study Design
A 5-year prospective cohort of 400 adults aged 25–75, with annual assessments of glabellar wrinkle severity (photographic scale), muscle strength (EMG), and BoNT-A dose, controlling for prior treatment history, skin type, and sun exposure.
Limitation: Cannot isolate age as an independent factor if it is tightly linked to wrinkle progression.
Cross-Sectional StudyLevel 4In EvidenceThe current association between age and BoNT-A dose in a representative population.
The current association between age and BoNT-A dose in a representative population.
What This Would Prove
The current association between age and BoNT-A dose in a representative population.
Ideal Study Design
A cross-sectional analysis of 1,000 patients receiving BoNT-A for glabellar lines, with age, wrinkle classification (3–5 scale), muscle strength (EMG), and dose recorded simultaneously by blinded assessors.
Limitation: Cannot determine if age causes higher doses or if both are driven by cumulative muscle use and skin changes.
Randomized Controlled TrialLevel 1bWhether age group (e.g., 30–45 vs. 55–70) influences dose-response to a fixed BoNT-A regimen.
Whether age group (e.g., 30–45 vs. 55–70) influences dose-response to a fixed BoNT-A regimen.
What This Would Prove
Whether age group (e.g., 30–45 vs. 55–70) influences dose-response to a fixed BoNT-A regimen.
Ideal Study Design
A double-blind RCT of 120 adults (60 aged 30–45, 60 aged 55–70) receiving identical 8U BoNT-A in corrugator/procerus, measuring wrinkle reduction and muscle strength at 4 weeks to test if older adults require higher doses for equivalent effect.
Limitation: Does not reflect real-world dosing practices where clinicians adjust dose based on clinical judgment.
Evidence from Studies
Supporting (1)
The study found that older people tended to get more Botox injections in their forehead than younger people, which matches the claim that older age means more Botox is needed.